Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2006
11/30/2006US20060270689 Novel Fused Heterocycles and Uses Thereof
11/30/2006US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006US20060270681 Pyridazine derivatives
11/30/2006US20060270676 Hydrazono-malonitriles
11/30/2006US20060270666 Quinoxaline derivatives as neutrophil elastase inhibitors and their use
11/30/2006US20060270665 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity
11/30/2006US20060270660 Processes for preparing substituted pyrimidines
11/30/2006US20060270618 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
11/30/2006US20060270608 Drugs for chronic pain
11/30/2006US20060269627 Isolation of a Dual Cox-2 and 5-Lipoxygenase Inhibitor from Acacia
11/30/2006US20060269603 Controlled release tramadol formulations
11/30/2006US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006US20060269548 Lymphatic endothelial cells materials and methods
11/30/2006US20060269487 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
11/30/2006CA2608678A1 Organic compounds
11/30/2006CA2608375A1 Organic compounds for the treatment of inflammatory or alleric conditions
11/30/2006CA2608134A1 Phospholipids for use in the treatment of an allergic inflammatory condition
11/30/2006CA2608036A1 Medicated product for local use based on natural materials
11/30/2006CA2602965A1 Tricyclic spiro derivatives as crth2 modulators
11/29/2006EP1726587A1 Benzothiazin-3-one compound and intermediate therefor
11/29/2006EP1726585A1 Diaryl-substituted five-membered heterocycle derivative
11/29/2006EP1726584A1 2-aminoquinazoline derivative
11/29/2006EP1726582A2 Compounds and methods for the inhibition of the expression of vcam-1
11/29/2006EP1725567A1 Spirocyclic cyclohexane derivatives with affinity to the orl-1 receptor
11/29/2006EP1725544A1 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
11/29/2006EP1725538A1 Pyridazinone ureas as antagonists of a4 integrins
11/29/2006EP1725529A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
11/29/2006EP1725232A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
11/29/2006EP1725228A2 Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
11/29/2006EP1725227A1 Use of new lipoxygenase inhibitors
11/29/2006EP1725226A2 The treatment of inflammatory disorders and pain using beta-aminoalcohols
11/29/2006EP1480624B1 Pharmaceutical tablet
11/29/2006EP1313504B1 Methods and compositions for inhibiting angiogenesis
11/29/2006EP1259223A4 Protein matrix materials, devices and methods of making and using thereof
11/29/2006EP1248804B1 Recombinant antibodies to human interleukin-1 beta
11/29/2006EP1248604B1 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
11/29/2006EP1218403B1 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
11/29/2006EP1114028B1 Aza-bicycles which modulate the inhibition of cell adhesion
11/29/2006EP1043995B1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
11/29/2006EP1023049B1 Preparation of a directly mouldable tabletting auxiliary
11/29/2006EP1021406B1 Novel anandamide amidase inhibitors as analgesic agents
11/29/2006EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide
11/29/2006CN2841006Y Plaster for abatement of fever
11/29/2006CN1871360A Method of detecting regulation effect of synoviolin activity
11/29/2006CN1871240A Pyrrolopyrimidine thion derivatives
11/29/2006CN1871234A 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible no-synthase
11/29/2006CN1871227A Antitumoral agent
11/29/2006CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006CN1871012A 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity
11/29/2006CN1869071A Recombination immune therapeutic protein and its expression method and application
11/29/2006CN1868538A Composition contg. scorpion protein and SOD used as food and medicine
11/29/2006CN1868537A Therapeutic effect of type II collagen allosteric peptide for treating rheumatoid arthritis
11/29/2006CN1868535A Medicine composition for treating rheumatic arthritis and rheumatoid arthritis, and its prepn. method
11/29/2006CN1868521A Traditional Chinese medicine tablet for treating medical arthralgia-syndrome and its prepn. method
11/29/2006CN1868517A Pure traditional Chinese medicine for radical curing of rheumatoid disease at base of of cause disease
11/29/2006CN1868516A Medicine for treating fracture and injury
11/29/2006CN1868515A Traditional Chinese medicine for treating rheumatism
11/29/2006CN1868512A Traditional Chinese medicine soft capsule for treating rheumatism and ostalgia, and its prepn. method
11/29/2006CN1868510A Plaster for treating traumatic injuries and rheumatism, and its prepn. method
11/29/2006CN1868509A External use medicine for treating rheumatic arthritis, and its prepn. method
11/29/2006CN1868502A Medicine composition used for treating rheumatoid arthritis, and its prepn. method
11/29/2006CN1868491A Medicine for radical cure of rheumatic arthritis and rheumatoid arthritis
11/29/2006CN1868466A Buluoweima slow-release tablet and its preparing method
11/29/2006CN1868463A Slow-release prepn. contg. alpha-lipoic acid or its derivatives, and preparing method therefor
11/29/2006CN1286834C Benzothiazoles compound
11/29/2006CN1286822C Pyrimidinone compounds
11/29/2006CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
11/29/2006CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006CN1286530C Self-regulated apoptosis of inflammatory cells by gene therapy
11/29/2006CN1286500C Medication for treating joint pain
11/29/2006CN1286498C Chinese medicinal powder for treating dysmenorrhea
11/29/2006CN1286495C Medicine for treating rheumatoid arthritis and ankylosing spondylitis and its preparation method
11/29/2006CN1286492C Traditional Chinese medicinal plaster
11/29/2006CN1286466C Chinese medicine sapogenin w3 for treating rheumatism and preparation and use
11/29/2006CN1286463C Dry cow mamma perfusion agent for preventing and curing cow mastitis and preparation method thereof
11/29/2006CN1286457C Freeze-dried powder injection of andrographolide and preparation thereof
11/28/2006US7141674 Anti-inflammatory compounds
11/28/2006US7141656 In situ screening, isolation of peptides; major histocompability complex
11/28/2006US7141599 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin
11/28/2006US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006US7141573 Huntington's diseases, Alzheimer's diseases, psychological disorders
11/28/2006US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
11/28/2006US7141566 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/28/2006US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
11/28/2006US7141365 Methods for diagnosing a mucin production associated disease condition
11/28/2006US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006US7141262 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents
11/28/2006CA2379786C Purine derivatives
11/28/2006CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006CA2268305C Use of an h+, k+-atpase inhibitor in the treatment of nasal polyps
11/28/2006CA2239853C Indane dimer compounds and their pharmaceutical use
11/28/2006CA2173582C Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
11/28/2006CA2160444C Aroyl-piperdine derivatives
11/28/2006CA2150945C Ibuprofen-containing effervescent pharmaceutical composition and process for preparing the same
11/28/2006CA2137203C Protein kinase c inhibitors
11/28/2006CA2035888C Nucleic acid coding for human testicular angiotensin (eca) conversion enzyme, its applications, in particular for in vitro screening of this enzyme in the organism
11/23/2006WO2006124731A2 Compounds and compositions as protein kinase inhibitors
11/23/2006WO2006124676A1 Methods and compositions for the treatment of autoimmune and inflammatory diseases associated with toll-like receptors
11/23/2006WO2006124668A1 Methods of using pnkp30, a member of the b7 family, to modulate the immune system